22. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 2011; 186:1077- 83; PMID:21784468; http://dx.doi.org/10.1016/j. juro.2011.04.110. 23. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6:e1000879; PMID:20300657; http://dx.doi. org/10.1371/journal.pgen.1000879. 24. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, et al. MicroRNA expres- sion profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metasta- sis. Urol Oncol 2011; In press; PMID:21880514. 25. Necela BM, Carr JM, Asmann YW, Thompson EA. Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer. PLoS One 2011; 6:e18501; PMID:21532750; http://dx.doi.org/10.1371/journal. pone.0018501. 26. Pasquinelli AE. MicroRNAs and their targets: recogni- tion, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012; 13:271-82; PMID:22411466. 27. Li X, Shen Y, Ichikawa H, Antes T, Goldberg GS. Regulation of miRNA expression by Src and con- tact normalization: effects on nonanchored cell growth and migration. Oncogene 2009; 28:4272- 83; PMID:19767772; http://dx.doi.org/10.1038/ onc.2009.278. 28. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, et al. The tumor suppressive microRNA miR- 218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011; 71:5765-78; PMID:21795477; http://dx.doi. org/10.1158/0008-5472.CAN-11-0368. 29. Fish JE, Wythe JD, Xiao T, Bruneau BG, Stainier DY, Srivastava D, et al. A Slit/miR-218/Robo regu- latory loop is required during heart tube forma- tion in zebrafish. Development 2011; 138:1409- 19; PMID:21385766; http://dx.doi.org/10.1242/ dev.060046. 30. Simion A, Laudadio I, Prévot PP, Raynaud P, Lemaigre FP, Jacquemin P. MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2. Biochem Biophys Res Commun 2010; 391:293-8; PMID:19913497; http://dx.doi. org/10.1016/j.bbrc.2009.11.052. 31. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A 2011; 108:9863-8; PMID:21628588; http://dx.doi. org/10.1073/pnas.1018493108. 32. Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, et al. Functional role of LASP1 in cell viability and its regulation by microR- NAs in bladder cancer. Urol Oncol 2010; 30:434-43; PMID:20843712. 33. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008; 27:2575- 82; PMID:17998940; http://dx.doi.org/10.1038/ sj.onc.1210919. 34. Li Q, Zhu F, Chen P. miR-7 and miR-218 epige- netically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast can- cer. Biochem Biophys Res Commun 2012; 424:28- 33; PMID:22705304; http://dx.doi.org/10.1016/j. bbrc.2012.06.028. 35. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, et al. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL- rearranged leukaemia. Nat Commun 2012; 3:688; PMID:22353710; http://dx.doi.org/10.1038/ncom- ms1681. 1114 Epigenetics Volume 7 issue 10